Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Iterum Therapeutics plcListing unverified | AwardD (derivative) | $1.4T | SEC | ||
Iterum Therapeutics plcListing unverified | AwardD (derivative) | $110.9B | SEC |